2026 NPPES data Internal Medicine Physician NPI 1740235183 M.D.
Verify on CMS →

DAHAN AL-FADHL, M.D.

Internal Medicine Physician in MISHAWAKA, Indiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
6K
Medicare Part D claims · 410 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$91.32
5 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: DAHAN AL-FADHL, M.D. is a Internal Medicine Physician ([object Object]) practicing in MISHAWAKA, Indiana with a Medicare Part D prescribing footprint of 6K claims across 410 beneficiaries — 12% brand-name prescribing . Industry payments of $91.32 across 5 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: DAHAN AL-FADHL, M.D. filed 5,995 Medicare Part D claims in 2023 across MISHAWAKA, Indiana. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

DAHAN AL-FADHL, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

DAHAN AL-FADHL, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 05/24/2006

NPI 1740235183

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

5,995 121% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

Specialty distribution in Indiana

How Internal Medicine Physician compares to other specialties among Indiana providers

Indiana providers

Internal Medicine Physician share within Indiana

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within Indiana

Specialty board-certification context

Estimated specialty board-certified rate — Internal Medicine Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Internal Medicine Physician ABMS/AOA estimate

Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DAHAN AL-FADHL, M.D. is a Internal Medicine Physician provider practicing in MISHAWAKA, Indiana, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1740235183. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DAHAN AL-FADHL, M.D. appears in the CMS NPPES registry as a Internal Medicine Physician provider holding M.D. credentials at 611 E DOUGLAS, MISHAWAKA, IN, 46545, with a listed phone of (574) 335-6232. NPI 1740235183 was issued on 05/24/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AL-FADHL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 5,995 prescription claims written by this provider, covering 410 Medicare beneficiaries and totaling roughly $695K in drug spend, split 12% brand-name and 88% generic by claim count, with an opioid prescribing rate of 1.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

611 E DOUGLAS
MISHAWAKA, IN 46545

Provider Details

NPI 1740235183
Specialty Internal Medicine Physician
Credentials M.D.
Gender Male
NPI Issued 05/24/2006

Hospital and facility affiliations

Facilities where DAHAN AL-FADHL, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

HONOR PHYSICIANS LLC
MISHAWAKA, IN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DAHAN AL-FADHL, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$91

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

DAHAN AL-FADHL, M.D. — brand share 12.0%
Specialty average (est.)

12% brand-name claims vs 88% generic, on 5,995 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

5,995
Total Claims
$695K
Total Drug Cost
410
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
14,515
Total Day Supply
425,081
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$587K
Generic Drug Cost
$103K
Opioid Claims
98 (1.6% rate)
Antibiotic Claims
194

Patient Demographics

Average Patient Age
76.4 years
Avg HCC Risk Score
1.29
Gender Split
51% female / 49% male
Age Distribution
<65: 18, 65-74: 151, 75-84: 177, 85+: 64

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
288
Amlodipine Besylate
280
Atorvastatin Calcium
256
Losartan Potassium
238
Metformin Hcl
236
Simvastatin
219
Lisinopril
195
Metoprolol Succinate
123
Omeprazole
112
Hydrochlorothiazide
107

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How DAHAN AL-FADHL, M.D. fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

DAHAN AL-FADHL, M.D.'s 5,995 claims are above the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in Indiana

Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as AL-FADHL.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DAHAN AL-FADHL, M.D.'s specialty?
DAHAN AL-FADHL, M.D. specializes in Internal Medicine Physician and practices in MISHAWAKA, Indiana. Credentials: M.D..
How much does DAHAN AL-FADHL, M.D. prescribe under Medicare Part D?
In 2023, DAHAN AL-FADHL, M.D. wrote 5,995 Medicare Part D claims totaling $695K in drug costs for 410 beneficiaries.
Where is DAHAN AL-FADHL, M.D. located?
DAHAN AL-FADHL, M.D. is located at 611 E DOUGLAS, MISHAWAKA, IN, 46545. Phone: (574) 335-6232.
What is DAHAN AL-FADHL, M.D.'s NPI number?
DAHAN AL-FADHL, M.D.'s National Provider Identifier (NPI) is 1740235183, issued on 05/24/2006.
Does DAHAN AL-FADHL, M.D. prescribe more brand-name or generic drugs?
DAHAN AL-FADHL, M.D.'s prescribing is 12% brand-name and 88% generic drugs by claim count, with $587K in brand drug costs.
Does DAHAN AL-FADHL, M.D. prescribe opioids?
Yes, DAHAN AL-FADHL, M.D. had 98 opioid claims in 2023 with an opioid prescribing rate of 1.6%.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does DAHAN AL-FADHL, M.D. prescribe most often?
Based on 2023 Medicare Part D data, DAHAN AL-FADHL, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Amlodipine Besylate, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DAHAN AL-FADHL, M.D. accept Medicare?
DAHAN AL-FADHL, M.D. appears in CMS Medicare data with 5,995 Part D claims and 410 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DAHAN AL-FADHL, M.D.'s credentials?
DAHAN AL-FADHL, M.D.'s NPI is 1740235183 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology